-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 SrXTUAdKwAYmS0s9iASVawtl6lOVWs+ikdZR2aXZdgjApO+1hJDi4160aWjR1cyR
 bbwy4IOo/0eNJ02DbBZ84Q==

<SEC-DOCUMENT>0001193125-10-279475.txt : 20101213
<SEC-HEADER>0001193125-10-279475.hdr.sgml : 20101213
<ACCEPTANCE-DATETIME>20101213171201
ACCESSION NUMBER:		0001193125-10-279475
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20101207
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20101213
DATE AS OF CHANGE:		20101213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMERICAN VANGUARD CORP
		CENTRAL INDEX KEY:			0000005981
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				952588080
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13795
		FILM NUMBER:		101248653

	BUSINESS ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660
		BUSINESS PHONE:		9492601200

	MAIL ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AEROCON INC
		DATE OF NAME CHANGE:	19720620
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 8-K
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>PURSUANT TO SECTION 13 OR 15(d) OF </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>THE SECURITIES EXCHANGE ACT OF 1934
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Date of Report (date of earliest event reported: December&nbsp;7, 2010 </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>AMERICAN VANGUARD CORPORATION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact name of registrant as specified in its charter) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>001-13795</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>95-2588080</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Commission</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>File Number</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(I.R.S. Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4695 MacArthur Court
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Newport Beach, California 92660 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of principal executive offices) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Registrant&#146;s telephone
number: (949)&nbsp;260-1200 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:3px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;1.01.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Entry into a Material Definitive Agreement </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px;padding-bottom:0px;"><FONT
STYLE="font-family:Times New Roman" SIZE="2">AMVAC Chemical Corporation (&#147;AMVAC&#148;), a wholly-owned subsidiary of American Vanguard Corporation, entered into two definitive Sale and Purchase Agreements (the &#147;Agreements&#148;) dated
December&nbsp;7, 2010 with Bayer CropScience Aktiengesellschaft (&#147;Bayer&#148;). Pursuant to the terms and conditions of the Agreements, Bayer agreed to sell, and AMVAC agreed to purchase, assets constituting the insect product lines Mocap
(globally) and Nemcur (globally except for Europe and Argentina); these assets include the active ingredient ethoprophos and fenamiphos, the trademarks Mocap<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, Nemacur<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, and Ultima<FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, registrations and registration data, certain rights relating to manufacturing and formulation know-how,
intellectual property rights and inventories as well as assets relating to Bayer&#146;s Ultima closed delivery system. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The information
contained in this Current Report on Form 8-K, including the Exhibit attached hereto, is being furnished under Items 1.01, 2.01, 8.01 and 9.01 and shall not be deemed &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of
1934, as amended (the &#147;Exchange Act&#148;), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;2.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Completion of Acquisition or Disposition of Assets </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">On December&nbsp;7, 2010, AMVAC completed the acquisition of certain assets constituting the Mocap and Nemacur insecticide product lines from Bayer. The assets purchased by AMVAC are described in the
disclosure under Item&nbsp;1.01 above, which is incorporated herein by reference. The purchase price consideration (which was not disclosed) was determined by arms&#146; length negotiation between the parties. The parties have been involved in
several commercial transactions over the past 10 years, the most recent of which was AMVAC&#146;s acquisition of the tribufos product line from Bayer on July&nbsp;21, 2010, as reported in the Company&#146;s Form 8-K filed as of July&nbsp;26, 2010.
</FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;8.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Other Events </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On December&nbsp;13, 2010,
American Vanguard Corporation issued a press release announcing that AMVAC had entered into the Agreements and completed the acquisition of the Mocap and Nemacur product lines as more fully described above. The full text of the press release is
attached hereto as Exhibit 99.1 and is incorporated herein by reference. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;9.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Financial Statements and Exhibits. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d)
Exhibits </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exhibit&nbsp;99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press release dated December&nbsp;13, 2010 of American Vanguard Corporation.</FONT></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, American Vanguard Corporation has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0">

<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">AMERICAN VANGUARD CORPORATION</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date: December 13, 2010</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">/<SMALL>S</SMALL>/&nbsp;&nbsp;&nbsp;&nbsp;T<SMALL>IMOTHY</SMALL> J.
D<SMALL>ONNELLY&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</SMALL></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Timothy J. Donnelly</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Chief Administrative Officer,</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>General Counsel &amp; Secretary</B></FONT></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>INDEX TO EXHIBITS </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>No.</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exhibit&nbsp;99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press release of American Vanguard Corporation dated December 13, 2010.</FONT></TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px">

<IMG SRC="g127916g91a21.jpg" ALT="LOGO"> </P>
 <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>FOR IMMEDIATE RELEASE </U></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>American Vanguard Announces Acquisition of Major Insecticides from Bayer CropScience </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Newport Beach, California &#150; December&nbsp;13, 2010 - American Vanguard Corporation (NYSE:AVD), today announced that its wholly-owned subsidiary,
Amvac Chemical Corporation, has completed the acquisition of two insecticide product lines from Bayer CropScience, LLC. The first includes the global product line relating to the active ingredient Ethoprophos (sold under the trade name Mocap&reg;)
and the second includes the global (except for Europe and Argentina) product line Fenamiphos (sold under the trade name Nemacur&reg;). Both product lines include registrations and data rights, rights relating to manufacturing and formulation
know-how, inventories, the Ultima&reg; packaging system and the trademarks Mocap, Nemacur and Ultima. Other terms of the transaction were not released. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mocap is a leading soil insecticide that is registered in 50 countries where it is used to combat many nematode species in a wide range of crops. Nemacur is a leading soil insecticide that is registered
in 30 countries for use primarily as a nematicide with additional efficacy against above-ground sucking insects. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mocap and Nemacur are
well-positioned in many high-valued fruit and vegetable crops, allowing them to achieve very attractive profitability. They can help professional crop protection users replace less desirable soil fumigants (such as methyl bromide), and are a
powerful tool against resistance development in numerous soil insect species. Each of these products has a well-recognized global brand identity and well-established worldwide distribution channels. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Eric Wintemute, President and CEO of American Vanguard, stated: &#147;We are very pleased to be able to add Mocap and Nemacur to our already extensive
insecticide product portfolio. As the &#147;products of choice&#148; in many specialized crop applications, Mocap and Nemacur have enjoyed an attractive competitive position and excellent profitability for many years. We feel that our considerable
expertise with insecticidal products will allow us to expand on the success that has been achieved under the excellent stewardship of Bayer CropScience.&#148; </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Wintemute continued: &#147;In light of the fact that the majority of Mocap and Nemacur sales occur
outside the United States, these products help American Vanguard to further our strategic goal of international expansion.&#148; He concluded: &#147;These transactions and others that we are pursuing underscore the importance that we attribute to
product portfolio enhancement and effective operational arrangements. Interacting with our industry peers to expand our product offering, achieve manufacturing efficiencies and distribute products effectively to a global marketplace is an important
objective of American Vanguard. We look forward to consummating additional value-adding transactions in the near future.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>About
American Vanguard </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets
products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000&reg;&nbsp;&amp; Russell 3000&reg; Indexes and the Standard&nbsp;&amp; Poors 600 Index. To
learn more about American Vanguard, please reference the Company&#146;s web site at <U>www.american-vanguard.com</U>. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>About Bayer
CropScience </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer
CropScience AG, a subsidiary of Bayer AG with annual sales of about EUR 6.5 billion (2009), is one of the world&#146;s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The
company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 18,700 and is represented in more than 120 countries.
This and further news is available at: www.press.bayercropscience.com. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Contact:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">American Vanguard Corporation</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Equity Group Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">William A. Kuser, Director of Investor Relations</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">www.theequitygroup.com</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(949) 260-1200</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lena Cati (212) 836-9611</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>williamk@amvac-chemical.com</U></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Lcati@equityny.com</U></FONT></TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g127916g91a21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g127916g91a21.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`1@$V`P$1``(1`0,1`?_$`+D```$#!`,!````````
M```````!"`D"!@<*`P4+!`$!``$$`P$!``````````````@!!08'`@,$"0H0
M```&`0,#`0<"`P<"!P````$"`P0%!@<`$0@A$@D3,4%1(A05"F%Q,B,6\(&1
MH;'!0A<8T>'Q4H(S)!$``0,"!0($`P4$"`(+`````0`1`@,$(3$2!09!!U$B
M$PAA<3*!D4(4%;'!4B/PH=%B,R07"9*B@K)#4V.C-"46)QC_V@`,`P$``A$#
M$0`_`-H+R@YCRIB:LQSS&=^EZ6Y5:D%PK%/%6RH@=&1,=812(N!1]!`P@90"
M%#L$>O;L,L_;%P;BO,;RO:\DLHW<*;Z=0?(P&>#XGXXD88X1Y[W<IWWC-.%;
M9[J=O*<HQ>);,2)`<'$B.`PPU%\&.F-FGR?>1J&=F7KO-C+3<OW20(!82X'^
MB7)]=+-U&Z7J-S`!VB_RI]Q0`R9"&^4.P`^GVU>V?L34MQ"ZXOMYJ",6>),O
MH!\_F`Q&)`R);%B\8ML[I\^&\5;2ZW*_`+$1,_I)$2"=(&!!+CH3\'3,I3S$
M>5=GLJUYZYM(5(JYA37LL:H<J9%U`+N55@<JYCG`"[CW&(&^P;:N%+VN>WVX
MI@RXSMPK$8B.I@?LD^3'#QQP6[=MYQR&K'16O+PS#`>>6)8>)?X_O3D>!?E^
M\GV2>:O%#'5XYGY5MM(O?(#$M3ME7E7%858SM?F[Q`1LQ&/3EB0="A*1[Q1$
M2I*%/L81W`=M8#W3]LO8O9>V?(-WVWCUC2O[7:+FK2F\WA.G2E.,XC6Q((&8
M(\<U?(\NW^G.`IW-P9FM`>>4R")2`(((R\3]B]-OZD4BG$4C=H*&#<.WW&[0
M_P"7P#7P[@&P_"`&^#Q!8?#%25K5#3GH'T@#]@/[T!),Q-Z?KD(IT`2J"!!`
M1#</XA#<-=_Y:L(ZR/(NL7EN3I,L5]B9P.'<4Q3E$`$#%Z@.^_L$.@AKJ*]`
MG">,%R:HJHT1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(
MT1&B(T1&B(T1&B(T1&B(T1&B(T109>8!RHA7(H44VWK))`JF=PW.X%</MDR@
M9J42O6W8DHJX3]38I]RCL`%$>X)O>T'3&K<:WU:6'SU4SX'%@6Q'CBS*)GN)
MC.<:6@GR3<]<-$XA_@3(,V+X=2M"K-SMY(/3NU3Q;YNZE),J3AH4P,VS(CZ2
M,R,4JCH_9L4P)IB!SA_-+T-ON'V+VZG3I6D*8U"(A3#$^;481+'K@7Z?!1)V
MR-&ENE2G2E.$X0'E/U&1$3*)\O0O*0P;2<1DFJ5#%F1LR7N`QQC6!834[:;$
MUK,6$C.1E7AU)::<%9Q$>[LMB>1%?9OI-=<"I-E'`++'.!44U!';7BY!R;:.
M([?7W;DM6%+;+2D:E80C.52-/XB&HO(8`Z1$2.)`P6_^-[?^;$)P,S6EH:(`
M<D]`#T?K][,I"./G$>X<,?*MPPPCF"^XH=9HJO*?CJQO..:',6BSR-(=S4_5
M;.T;2]D6K,31W3I.-D$".$6$B\5155`O:8`,(:*Y5W,VSN=V&Y)R78+6^I\;
MK;%N(MJUP(1C7C"G*$O3B)&H"XSE``AFQ6P3MUQ9[Q2HW,)QJ0N8:@6_C`Q9
MQFPP)QZKU/4!'L'H!OF-OMTV'?J`[[]0U\$*&3_W8?\`4BI5RZ`_4`'^X(6;
MI."'*JD0>XHEZ@`CL/P';]->N-24")`G!>>M0A7I2I2P$@RMB0@'P%]2%D/H
MG!2AL5<KA5(W;W&`@^DY1V*)A]X&V^&W37NI7](G1=TC*!\&#?'(JR5=EKTB
M*EC5,9C,%RXZ`8_M5N.[C,UY57^H8P#-R`F)%6*:VYR#\IA*8P&144[@$>WN
M`>WW`(@&O=2V:QOX:=MJ:+G^\1\_@?@K=6WS<-KJG]4AJMP'##IXX/\`:5><
M5:(*:*'T$DV55[2F,V,H4CI/N`G\:!A`_03@`B&X;C[=6N[L+VQ#W=*<(^+.
M/O#A9!9[OMFX?^CKTYGYL?N+%=]W!\?UUXA.,BP.*N24!WZZY)DC1$:(C1$:
M(C1$:(C1$:(C1$:(C1$:(C1$:(C1$:(C1$@AN&VB)0Z=-$1HB-$1HB!Z]-$2
M`&P;:(ET1&B('KTT1)VAMV]=O_/?1%!9Y@2NG$+7V3`Y%))VNU9Q[!)C)2+Q
MTY<1<X1%--K'.4E%>]P8GR@0YC``ATZ#J;_M#J6M&M=7-[4A2MM!)E.<81#3
MIX/(9D.QP;$XXJ*'N#I^L:5`0JU)3D(@4P3($QEB0,XD`Q8L!(B1)81.DAD7
M"N3+KDN/HS:(E(\\U.RH3M@F:M/L82FQ</\`<G%LM5L=^LL$!7*I&-'#UXZ<
M*]B#=L;8QS"4IOJI#F/&=HX]4W8UQ4%&A"-M&$XS-6XJ-Z=`,VJ4A],@,2P8
M$J)G'=GJ4MRK4S0JQC2.4S$2TRTD/Y?,SXB(RQ.D"39V\/5*-R7\I_$3%L#*
M,?\`H-QMM5TSBQCV]?D&*%K'&,8ZDH[*MP0>R#M92XWFS!$F47=J'"-:G38-
MR)HHE(;0GN9W&OP[LEOO(YU)2Y1O5*A:DS.HQIWD=%6WI&+1>D"?/%S(1),=
M1<2O[?6U*XWNA0-,`0J1E*3@1`HG7(&+9-!CBSEW.`3>L%9?EN0_GEQCF>;E
MFY'&3/(M!V,J22RRR?VHF9&S&O1:/:H9,Z32`8-42'W*7L2+[`V`<LWWCEMP
MWVEW.Q;>=5M2X76DV1UU;37(G,$R(,C]RNUQ7G?<BE.I&3F[AYL&`,]3],!]
M/7/#Q'H.\G_,%XYN%=]N.)^2O)>MXWRA2*E!7Z>Q\I6,@6*U&J]H.I]GD86-
MJU3FAL)CH)&7<(L3+K,FH"NX*DB`G#X)VY!C@^`@/^2*E!-GU#\0!_J;]RZ?
M&/FO\6F9LTX[X_8PYG8CN64,KL(EYCZ)BG-@^S65[.$24C:DRN3B!1IR61%@
M<)D-7%WZ,VDNH5%1L58Q4Q]"X*Z.5?EW\=O"C*$=ACDGR6J]`R:]CXN:?5)I
M`7FZR-1@)I4J479,B'H56LS3'5=?>JF=-Y-*,DC)*D4W],Q3"17OR$\D/`[C
M-5,0W+D+R3Q30<?\AXV2E<,W&7DG<U3,E0\5#1$Z^E8&Q5^-FH-:()#V!DLF
MY56207*Z3!(QS&`-4C$0J>K`D5/$%<*D(U8^G5$94_`AU'=FOG1'VW/'C-:<
M3\K\7GV"N>)+9,L%\K/,LU?,ETKM<6KI8Q]QYA&,$WC/NAR.U@>)V4S4Q%12
M!,H[FVS+:.4U+>I"A?B,[(OK?$D$%OAFW3)8=O/$Z%>C.XV[5#<`Q@V6$@3A
MAF'ZX9XY+(^9?-/PNX<9F2XZ<G.1]'JN5$7,(A,5&63G5Y:HEL18Q>(<7FQ1
M,=)UJDQSJ+D479#R[EL`MUB*F.5,X&U<KS;>)WFDV%S&C=5(NV<7#X$="2P&
M(^2MUA><RH5#"ZM_4V^!`./G/R/@WP/7Y)T&>/+%X_.+U.I=TSSR5HM`C\C$
M16H$08)JTW"[L5P8*)S51IE)BK-9[%7`;RC94\DT:JLDTUR"=4O<4!P_=MHO
MMGKQHW<"3,/$@."/AATZK+MGWG;]WHSE9R:5*0C*)Z$Y8EG?HRO4WDHX,!Q5
M8\WB\E\:J<4Y"790*6;"/90]2;S4A8R5)O$2A4XE29AI0EC4*T6;NVB"K94W
M\T"%^;5HC*9+$,%>%;?&_P`K/COY=Y>L.!N.'+7$.6<M5LDHNXIM8F7XO9EG
M"%[Y>3ICV3BXV(O\1&I@8ZSN"<2+9-(HJ"?T_FUV*BD$4$0(82[B(!N`!U$1
M]P`'O$=$4(/%#RA94OWE#\AGCLY.TO&6,2\8JK$9EP';ZTI9H][D?`,DNT=R
M%OMZMFFY*+</Z_!6N`%TO&D:M4W9WI!3`$@[2*T^#_F?J.1>&EXYX<[;C@;B
MQ@"T\D<HXSXLS;R0M4$]REBBCR#J+KUI<Q=@DK#+V2[69W#R8@R@VIR>A'**
ME2`H_*12#8N\E_`O-6!LC\F\6\I\27+!F'VP.\K7^.GED6.-D#(@X2->XE^R
M:6.J'<(?.D1ZS1.J4!$@&`!V(K=PSY7O'#R(S)'\?L(<SL`9/S!+L`D(6DU"
M^,9-_82!&N9EPTK#TJ9(:S2T?%,UG#M@Q=+OF:21S+HI@0VQ%].;/*CX[..&
M8E,`9TYCX`Q7EYM'(RDC2;I?V$/(P;9TR+),$[([43/#UF0DXXY%VK20<MG;
MI)5,R*1P53$Q%DTW.SA\2$X^V4W(S$H5WE?-)5SC7-C;XX([-U@6>M(Y.&QR
MY[A2L4B=_(((@DD/<*JQ2@&XZ(K]B^3G'V:ON:,71>8L=N\A<<X>#L.>:B%I
MC$9G$4!9(-6S0<W?VZZR9:U%25=;J/4UW)DTA;$,H(@4!$")O."O*=XZN3>3
M289P!S,X^Y7RHY%[]LHM0R'#OY^P%C6+F4DCU5JH=`ML3CXQFJX6-&F=%213
M,<P@4HCHBN>,\C/!B<S-&\=8'E9@Z>SO+Y'N.(V&(H2^Q4OD$<D8^CE92ZU)
MY6(XSJ3C).M-4#_5"Y(DBF<OI]_J?)HBC%\EWY`?%#B7@_*TQQBSAQCY'\FL
M5Y*H-`EL`J952"3.-@NK"KW!9NE75AD9AW2T7"IGP1PNB1ZZ1B.NPQ1)HBV`
MXYR=Y'L7:A"IJ.F;5R=,@B8I#KH$5,0IC`!C%*8VP"(`(AHBC]\G_D7Q;XO^
M*=CY+Y+@)B\/3S\+C_%^,:XX(TL.4,IVHCU2MTV->JMWB<<BHTC';UZZ]%<[
M9BR6.FBNL":"A%%7@KRQ>5#'V:>-\/Y*/&BPPKQ[Y<3B%6QWDS`,[9\JVG"E
MLLOVY>FQ'(FIL9*U/JXP61D")23U5O$%8;G6%$`:N4$R*8SDMY'."O#JTUVD
M<G^5>$\)7&UMT7T'5KW=XZ,L3F+<+K-49QS#)_4R$77U7+95,L@\(W9"HF8O
MJ[E'8BOW(',OBGBK'N,<MY'Y$89I.+,TR5>A\29(LF1*W%47(TK;8Q::K+&H
M6IP]+"S2D[#MU'3445C%503,<![2B($6+A\FWC]1QOCO,,CS#X]0V*LO3UUK
M.*\BSV3:_`4[(,YCF15BKNPJL_..(Z/ESUE^D*;HZ)SIE'82F,4Q3"RSR19`
MXS\XN(?,EC:Y#BSR-Q#GAO1%(]*ZEQM=(NQ.ZH:7-)$AU+#'-U"R$0UF!AG8
MM%ETB).0;*"F8P$,(4U1.`=_B"$6+:AY4?'!?<P-\!4SF_QAL^8GT_\`TI&4
M&$S#3Y";F+3]6Y8?TQ"^A(BRFK']<T.C]"T66=>J`%[-S%`:HLC96YY<-<%7
MEUC',W)O".,<CLV=1D5L?W3(=?@[L9E?)H*[3G+:K/'1)EZG99LP-F?HHJ"L
MH!M@V*8=$5H<@_)=P&XHWUEBSDARYP'A?([YE&RB=(O^1(>#LC>*F#.2Q<O)
M1:ICN(B(?_2*"D[=@BW.!!$#[==$36>?'FFXL\"KQPPJEOLE`MT9R^OE19?U
M:CEFOU^#QC@VU[@ER5DW!HN;:63&#<Y#E*X17:H+"7<K@`WV(LFQ7-O(LQY/
M&'#>)0XW2&#)/B^TSE'V5OFR%7Y(OIM\\339F;84+,_>U,:N6"Q%"38,/I3&
M,`>MW#VZ(LHVGR>^/"D9J4XZ7#FIQHK6;T+$2H/,:S67JA'V>-MJCAJT2JTN
MT<2!$8>R+NWJ22;!THDZ44/VE((@(`17]GWG3PYXJSD96N2W)W!>![!-U][:
MX.$RMDRKTF8FZW'/%(]Y,Q$;//V3J28HOTC(=R)3]RP"0H";H)%U<;Y!.$LS
MQLL',*(Y282E.,53>(1MIS='WR'>8_K<LZFX6MMH6=FFZR@1,ZXGK''M",5R
M)NSN'S<@)B*R?<1,)\O$N_K5*CYF">NXB=DW18%"<:&*B[BHY&&>O)!"-=%0
M76:/98'H)G.0Q#F;)JI@(@<Q1F5[2;.UW3?*NV[A3A6V\!]$OIE(SB(&8<:H
MQ8L"X$S&1R!$7/<%*I:QIW="IHE`A\6<:)^5PQ&HZ7+L!'H^.F5F.2L''3"$
M1D^+O5QKN?N3%BF1I$G%D2:2U9XYU27<M[#;7[A)DF]CGF7,D0:$?&"`E0<P
M4,](<@H/=Q^DUC:[9W%YO+BUY94+7A''7A<3C'`[K(`T8#/7Z=OC)_Q58'4\
M"\?>/6OZ3;#?KZH?UBZ#TZ<JI(%'Z9,\B3CDTB[&7FP3N_%*5M@K`?D.\H[)
MNM`!0^$=OQE!F%%)"'CN25YM"T?(E@6K9BBS3:RSZ'KTHDP2`469ID4"E*D5
M("Z?]R%Q=\HY9POL%N!%2-;DE&[E`82-A3HZY1D7U92J/,G5@X.+#>_;N%.V
MMMRW2J#KI4C3ISU$"4KC3$1.0)B"6)RP)R<PH^)%Z\=>3+@:Q56!X<W)G%*J
MR_9ZACC_`%<P7<*&6.F40564$3B81[A-T]FI">X&1H=B.2TZ#1H4=BK4H`9"
MGH]/2QQ^DX'/P.:]=G;TOU2WKQ`'^9I@!SAY@V#XL/A\5O#SF`<DR_G*\B67
M);"5WE\96OQ'Q6,,>9,?XREGE%L%X4?Q1IS'M9M[N)5A)RU/&2P@O'MECN5$
M@.D<@E((:_/1;PB+,5(CS&,7/Q`8_L`4I0QE3@>L?WYJ$&H<)>3#+Q\_C65N
M/XDYP89&P7Y"YZZYZ@T<)W!C<,6U5UR.+./KADYF>`2DJC7WT.T;O/KI,$$%
M6R!%`.)4R[>N<(1E%FTZ8OCU(<KCD<5GGFG@//V".?GE]<Y"H?E&MF(O(!3<
M=O<7R?`'`F,\S4_.583Q'-X^G\"Y?NEXQ%DZ6Q*XB9"2/&M%F:C4B4>)WBJ2
MIBLM^J@TX&4@"TCUS'P5)"1!$"TO'-OL5V\G/'CDQQCC\8W!2G%O/=RQC@O/
M;Y[R!H60H9IFR4PQCBTW;$-B;USD#;\<TV(H+.+AHDZS%P99DS8`W8JH*=_H
M*F&@8US#\`B/O;^F2Y*0GR;<<<DRWF'\#%JPW@JYO<)8'M^>%,@V7&N,I5?&
MF(HN?:4I"!3M,O6X0]:I,;*+LERH%<G;IF[#F+ML(Z19_-DQ_853#JH]\DDN
M'$C-'F[Q#G7Q8<B>>UQYN\DZ]ECC;+5;`MTN^%,WXYL;2'7K.,K5F:JQ$DMC
MUMB#Z@3J!U])R@JF`)F(`G[;&O=TM-2W`)#F3@:3'(B0.&(RS9>:ZMZ=Q2-,
MU#3J]",P>A'3#^S-E87D0PORFPIRG\="$#QLS'AK!M:XJUL97*7"CBZVY5YL
MX]Y6;LYU&4XLXAR?,TRVOL?P,.=)DPCY11DBHN@X.X'U$P5]+8]ES']4N:-I
M?1IV]C3H&F2(1E*K(X#&0)B9/I)BPP<,L1'&OTZVN;J,S6F:GJ#5/3&,HXB<
MP&U:9,6/@6*CV4IW*"6_'3Y0<7#X&SHZR7:.<SV\HXTMN,+:EFL(U7+%#N#N
M;?P;."9+RYEVC?O>N6S8[0JQ%O3$@%$`Y5."2N>(_KEK2NH[F;B41"0#&!J$
M1+,Y(&)D"Q8_!=-'EX'*SM%:M:2VX6XE*0F`1,`F6+Y$X?`,I[65&CK7Y[_$
M9DC"N(I.(Q1B_P`?.6*)?IRO8V=0%:QQ.(T+*L/`4BVRD=$HP,))-/N*+9FR
M,X$2@X*5,-E`[L4W[B'(N-U"-UM9PM],2*@!E`B0!'F&`S`8L7<-@KWLO*=A
MWR&FQN82NA(Q,"0)."1@.H+$O%PS>*VR"C\H;B&^P;_OMUUC(E&7TEUD66:U
M&OR+L.<M<69GQ/S2X%X8N^7LO9ZXQ<A?&OFF'QY1+%<9J,QYEV.)8*!D%8U6
MC)%:(/3I]:2,1\\*FW37*U(90I0$![(`$L?Z?%%R^2#`N1>%G$[PJ8"QUBY*
MPTCCK;J32<Q<GX3A^7F7>N+SFJ5&CF<YDQ]C5O6;5#Q]LM5X;/ETWZT*_$SA
M$G8F<^Z:U)`"1;)%'!QSP1R+D>-7Y.Y'^&^:4W.<E:!4K-@Z;Y!<>+!CW,?(
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M7'?)]*5S\E3\)WBFN8U.@24;`3]JCK,=FFY&%;K%DEV#Q!)<J*BXD*11U\5(
M3)N0.?/@9R+&U;.%BKF(YN=KN7HFJ^.NP\4.,_$:RW2O,D28.KUG8X]C9G($
MQ$V)ZN$Y/34M),#BJV7162!R[(!%-[XE^"4,[Y#^;/.EXX^1]3Y(3/D&Y.QG
M&S/^2,9/&5O@*=9H6>3KMNP_9K3#).&5><2]K=*'DX0Q2O2*&(=50A$R@1:W
M-@H;>I>$1GXZ[-P(Y-/?)'BKF:G;\@S$;Q`RE8EZ[%KY>7E"9(=9J:49:)>0
M5KQT[2A&*;:1<J/P[5"I"V$BVB+TX(P!+&QY3`<IBL6@"4Y!3.`@W3`0.00`
M2'`?:`^P=$6OO^2GQ?Y$<CN"N,[-Q@QY)9@R=Q8Y78@Y1!B>"CW,M8[[7L?L
M+?"2T778EB!Y"9DV2MM0=G9M2*NG#)!<$$U%0(0Q%958\V6>.8&9>).$N`'#
M'.C&=N]YC7_-FU\L\`Y/H5`XOXO9HM%[M$(6Y.3K,5+9*:F,Y3C``SAF[630
M3*F=5<Q$B*/N]NJ3P7\TOD[SMY'N(N9.1>).6V*L>1W$7*%;XWV7D95)2NPE
M5CHZS<>H9.*KLU&52TS1&K=@9%<6I"$B05<*I(NB*JD3$>0'!WE`W\#WB>XZ
M9<P;EYY*3ODX87*:PF2H6NR7?#G'K(LUF9U!5NY1\1'O92K-65;L@+K@^*U&
M.&1(V4])0@)@12!?D<8OXY<<K7X+*%!\<8N1XVT#FG8G,MQKPKC9B];VJHIR
M>*IJS56JXNK[$C6TRMC(9R)XY-$RTNX<&3-W'7,(LL47>\3ZH3EWSV\S/(?@
MAA7(N(>-68/'"AQVH4A/X7L7'2K9LY4/JS+,(RT5""ME;I2C5]52LU8]XNJ@
MBZ16=?4./3!R01J^#*@(.`S42]=J53O?C.X&>-?$7CPY&T#RGXFY78IL.1+?
M)\0[77)7$CR!R[8;!:\Z6?-KBK,6LG49FJO&I")KOQ32;D("H%28H*GIF`1D
M55;!4UP[HN??R;LAY*SOQ_0R;C7&WCCQK/8OM&0<=NI[&<;F2,RW%(LG\-*S
M$8YJ3V]5Z$DG:K4H*&=,^\RJ9"G3!0I%$YY:)/(EQY2>:;'*U&L>$K5;,$XU
MJN&*_BOQ^W+D3E_GG#,\3H@XDY#DB]J=^B,54&H/$?HGIH8(91!F3O\`J"O(
M]0QB+*6?:O*4_P`='XP^9;GAG)UFIO%[-'&U]R1&&PA?+];,<4VG4YI'6ME<
M*1&U.4NB,:QE(%RV^D.R%-PY2(FD10ZB`'(G]L:1?IK\IU#+\%2+VTQ;*^*Y
MK#Q.2G%%LS:DM9N3L!7T9#N)IW%H1#*9(B('&/643<E,0Q#)@8!`"*`JVTVN
MX\\5/+WQ;9<X(9XR+Y>;[RBO,G!6J(XMW6TR>:)Z9SI#VR%Y!5#/L/5';!S3
M6=!17(4594`6()_E,W<K&(132W+BC=K%YD_!A5N3&+5LV-L.>-*UUK--MM=!
M<7W&S;-=1QM;6HR5BL#^*E:@%A/<V!W+([I;UCNO263#O42,)$V_A1@:;B\5
M>9O&DO@Z=CL=6/S^<09*IX\DL5RS.CV#%#?R5\?/O#ZN5-U`)0<QCIK3X10[
MM5J@K&)1+;O4$K8@&T13N^2>&J=Q<MJMD66L%6QNW*QM%PN\%%N))[2V</%2
MZ7W6.:HQ$B61F)E-W]M:QX?SGSAPF"("=(=I;>WBZW+:;2>\<;HT;KE4P:%M
M:5)QCZLZLXCS$SCHC2;U95"=,!`ZCY@\7.\-IM>Z<AH[?O9J0V8UQZ\],M$8
M"G,O*0#'$Q:.J+EB[1*T9.;<RYM>6)*^^DVD<;A+MZU1(J)FBD:Q6.*FLZC:
ME0SMU(YK8ZV:/JL:FFX%TP:.U72BRYP]94=_K+VUM:&U\<H[%KJ4^3R`G=5)
MP,I5KVI#5<7&OS1)E,D^69B(Q$,E%B5P;G?)U8FG.R@94Z1,P7I4Y::<AIT`
MN,1A@_7,VX;R3H5;A+=.`$5QVKK7`=\RFURI;?H,O7XMYD9MLY@GJ,2E8G+%
MV`5[U*LR,=L#3O'TMA4$1'5BN^Q-+<>YMIW:N=]O*O+K#;OR5&/Y2V%$4]$X
MN#+$AID&0D)]`00RWWLG(J_Z3+8_+^4G5%7&`#RB!$.Q$1CB,,3CX+"_B.9M
M'WE&X+%9I.F#8.2^.W31N9<JYD$$9LKILT,]4;@=\9%#M2,H8H&.&XB!1$-K
MC[D8^AV#Y(*KFI2V>I&4S^(R:+-F<2"X.&&HE\<JV=Y;[;:1`^I7B&#X$D='
MPQQ'3`='"];4"[$]H]-NF_LZ!K\]E(-2B#FRE*"&`\`RK`!`#"(;"(>W?J.P
M#^H^S78B4#!L`;]>@>_1$H[^X-QT1)U[@^&W7K^_NT15".W4=$5(_,`@`B`_
M$.G[>W1!@73>LM\=:?D_UI(JCNL6I15!;^HH<K<PNCMBJE23E8]R0[9VD<JQ
M@.<GI+CN'\P0#;6><4[B;[Q24:-$BOMS,:<\@#UB001\L1\%A7(^![)R$RNI
MQ]+<#CK'4_'X_'[W4364L,Y-PO(-Y.24M<.FSF7WV^X5EHS>LE1D5I`S=PC(
M1T*JJR=.06`2@N4%DP[ODWZA+/BW-N*<YLOR=2-K.<H1$[>K(PD3$1?RRJ!Q
MFYB0"<`74=N1\7W[BMU.X-6M2IB`$:U.,9X$NP$8$ZG!)>,BV8)+J_,8^0"^
M4D(UCD-O(Y&@3NGC-1Z:$5C+6V0:D>@FJW=-XQFPDQ1!J4%`<)>LH!P,)R]=
M8_RWV\;#NQJW?&?3VV]$1,0U@TY2.G`O4)@)$X'5I'0%>_C7>^]VR%*AOHK7
M=K.1A$QHS,R(&0)TQ@9'RQ)R/3`*4#%7(C$>84$0I-P8O94S<[A:N/TG$/96
MQ$_3]<5(*21:OE4VPJE*=1(BB0"/\6HN<HX%R[A-2=/D-I4$(RPJ0:I3E$GR
MD3IF4<>CD$^"D#QGG'&N56L*^UW$!5D/\*;TY@C,:)B,G'7##JRS9ZI-Q+N(
MB7;<``1VW#<-^GZ:Q*)$HB0Z_?\`<LN(,6)!:18*HN^W7_/X:JB4Q>XIBB(@
M!@$!$/;L(;=/;UT10O9X\%'$#.V4.063QR7S#PX;E<LS=\D<?8"Y-W3&>*<S
MOFK$\<X=WFB-$I"-DQEFBRH.T0,FU6%=<?2`5UO4(I7L1XHQ_@G%V/<,8IK;
M*GXTQ93Z_0J+5XX53,X*K5>,;1$-')*N%%G+DR#)J0#K+'4664[CJ&,<QC"1
M9#$-PVT1(4!#???;W;CO\=$56B(T1&B(T1)MUWW']O=HB!#?WB'[#HB-NFVX
M_O[]$3%.77`#`',O)/$S+68W60&UHX4YB0SIAXU,LS6`BS75C(U>5(%Q:.8:
M4-.0A7-1:=R*:C4_9ZA?4V..O.;BD8DQ><1(Q.F)EYG;2``29$X`#,KE$2)<
M8$>.'[5AZZ<W[#R*R!-<>/'H6$R;:H%XYA\R\I))FZE>._&LZ3GZ1VT1D2E;
ML,SYD,B552+KD0X68I*%*M)N46X"FIN^R[4TN(;73Y7WB->PM*T14L]NC*,+
M^]<:HD0QG;6V0K5JL02'IP&LA]=W'+JN_74]FX6!7G">BO=@^2V.+MK#3F,#
M$1U1D,M0=I.(5D\CXI@P?R;V9>,V;5LXF'Y&*+Z47;MTDEI!VC&-F4:BY>J$
M%10C=%%`IS"!"%+L`:7D83N:U6G`TZ4ZCQ@[PB&``IN3(0#92+NY.:SNVI5*
M%"-&K4-6I$,9G.7Q(``!/P7:ATZ:JN]((;^\P?L.B)0Z?$?WT1&B(^'MZ?VZ
MZ(C1$:(H%_,A.R9:JW@T7LDVC3*QCQ9I%MTA,Z>(L)95)PN8S54[M4B)3(EW
M$WI`KLGV*&[M3I]GEE;4]X.[:*4KZGJTRF7TC5")`#LQ=SUP?$!1!]Q6Y7=.
M?Y"!F+64@)",7U-"4P3+,,0`X?'!L76AEGD$PEET#*V)=VM(JN#!N9LL4ZQ7
MZX?4"1L=!<5@#;<AQ$2F+N(=-?7_`&>(HV/ISTRJ,3J$=+&>)T@9&)+@XY.7
M"BOQ&,JU]4G2%#TIDM$X@>:(:+EP!T^19PF&S"I@.<PF<&V77,83M!,+CJ8P
MD$_H&/N0NP]P@)MRB`!OJ_4*`%/492U2A\@/$APXEUQZEV4A]JIPB=!C#4`!
MG@.F3]?#P3]?#0<3>5/@JW[U`#_N!J1SE*D45RJ)F>JE*YV:HD(F(;`.VP[]
M>NVM$^YT@^W_`)4'P_3)?!_/`8_>X^/VK/\`9*(.^6<A@1=4F;#\4<(N3FS'
MX.,'7K7`(=0-\?9[>FP:_/;#Z!\E)X9GYKDUR7))L'P#_#1%0;N`=]QV_?\`
M31%7T[@ZCO\`#W>_1$@B(;[EZ?N'^FB)"^\=MM]M@_;?1$N__N#8/\>NB+JI
M6%BI]@ZC)B/9R4:]2.@[8O6Z;EJX2.40,15%0HD,`@;]]<[:K6LKL7]G.=.\
MB`THD@ABXR/BO/=6EK?43;WE.-2B<P0HX.0?`>/GV@3>&GCB&E6K]604J#ET
MR2A7?U!717)(AVZ:&/&KB#GY4E5?0],O8!B;[#)'MQ[@J^U74MMYM3A=64J4
M8"MI)G%B""0)#5EBP)R+',:,YGV5L]R,;_C$I6UW2G*8@"`#(B0(!(+.)$'X
M`8J(.VU^[XGG20=F9Y!H]KCI"?*5R9)[&/3).G)7"4A'RC`!CG:78<G:JD=0
MOS_+Z@F$-3"VS=^-\TVN5[:U=OO-GJTJ?DEH,@PTF$J9.J/RPRQ9E&F^VG?N
M&WWY&5"]%[1E4,J\=>EYF1B8EF,HY.00)8@-(!.8POY(<Q412.;7Y%7)M5.7
MZ<_W=,S&W-D6B,?M]'-$;MV[MW],<YCD?`N917?^:&PF-JSF?MJXAR&G*ZXO
M+]/W$2>`B1*C,G5G$EXAV;0P;IDVP^*]]>0;1"`WW5=;<($2$XF-2(BV(('F
M+8'5U(4JF&.=7'?-BT7%P=P+6;3)-TE25&[M%:Y+^JH3?Z5LZ<">$D7`'`2]
MC=TH<1#;M`>FHH<S[)=R>#2JU]SLX76T0)_S-K+U:0#L\V\P\',0'^&*D9Q7
MNAQ'EH%.QK2I7A`:G5B8$EM1$2<"P_K!">"FH!Q$`$!V`I@V]@E-OL8!W$!`
M=N@ZU2)#48/YXYAB&^];"#D:F(B>N!!^3+EUR1&B(T1&B(T1&B(T1&B(T1&J
M$@8G`(L%\AN2F#N*F-)O+W(')M4Q9C^")LYG;.^%$7CP2]Z,3!Q;<J\O8YQX
M4!!!BP0<.UC?PICL.LDXCP[E7.MZI\>XG87%]NM631A2#M'^*<BT81!SE(B(
MZE6[<MVV_9Z/YK<JL:=NQ;K*1\(QSE]BA%@+/S'\RMM47CVF:>#GBV6AW*?W
M'9C2N27-*+FG*)2E8NC"ZL>'\5/XI,X'4;>DZ>LG0E!585=FLFKFV[=^V:R]
M.^IV?)/<+ZCBG+^98[+*&/\`,@/Y-S<TI2'UN!.`PCI\^O?7WOG=T*MO*K9\
M5IRTDQ8RK@2`E')B)-]428"+_P"(3A.QAC"&*N/..*MB+"](@,>8WI<:G%UR
MIUQBFRCF+<A2`HNJ(=SA_)/%"BHY=N#JN7*QC'5.8PB.HN\DY)OW+]\K\CY-
M=5KW>+F6J=2H7(_NP&`A3'X:<0(Q````"V'MNUV>TVPM+"$:="/2(;42SRG_
M`!U"V,SB<7S65M617!&B(T1&B(T1&B(T1&B)BO+3@[5.5[$K6?OMRIX&,D#@
MU:*S,*R2;59H!2_4B4R*A4UC&`P;E]0"B8H]H!K=7:GO7N_:BH)V.W6>XD`X
M5S*.+@N91QP(RZ@D=5JSG7:S;N:U#<7%W4MZQD':(G`@9Q,3@QP^YC@2H2K_
M`/B^X>O3@R__`'89<BB'6%50BE*JLHHJ;M,(>NNN^16<#ZJASF$XB)_E`PCL
M(FE/:_[AW)J%`T*_&-N)+8QN[F)#'H8Y>#>&'@VI=N]L5IM=T;FANHG$DX2H
M'R@D%HM4#9,,,`X";E*?B#XRD#G42YQ9&1.)5`1,?#M?4!$Y^_8Y"%NZ:0=O
M>/3M#V^T.FU['^Y'O@IQI_\`Q:Q!B&PO*[G_`(J9#^#X>*SFW[175L1^7O;8
MTW'U49.0/XB)@E9?X9_BZU_B%RFP;R58<Q9V]#A:_L+TE47^'6$'_49H]!V@
ME'N)Q"_R'T`F%P!A5*U5V[=NWKN&!]R/?3NW<;@FY<'EQ\65'<;8TIU)7/J$
M`L7$?3&((<8A7VP[=[E:;E1OJ]S;SI4ZD9:80D#Y2)8$R.!;%;8Q>ORC[=_X
MA]O3_7V:@93A*%*,)EYB(<_%;9D`[QZKGUS7%&^B)#!W!M[.NB)=O?[]$5)_
MX1_N_P!0T1(0>FWP_P!]]$50[;==MOUVVT1'0/@'^`:(J3``[;E[@W_N#V=?
MAJC`!NBH8@D$YA6#D/%U!RE#$@K[68ZQ1Z2AEF@/"JD=,')@`!=1L@V50?Q[
MG8-A.BJ0PAT$1#5WV'D.^\5NA><>KU*%7\0B0TAX2C)XR#]""/!6O>=BVSD%
MH;/=*4*M+,/F"S.""""WQ40N=_&A8HE=6:PI*2EMAO4577I<U.?361MZ[A!0
MZ<1+OW+:&D6I2)!N#DZ+CY0V,H;KJ7_!O<YMU_"G8<^HPL[D81NJ=,SIX1(!
M-*`E*!/4Q!B^+!1JY;V%NK&W-WQ&K5K:01*E.>J4P6)!,B-1\H'B7))\8B+C
M0)ZH2CR!NE;M5;EV:`(N(B>!:)=F.0Z:*KA1NZ>*)`Q5724$#)&%,QS]Q3F`
M>X)A;'R/;-ZL:-QM-:TNK;4XG3,:D`""P.D9MTD'&3`J.6[;;>;9&E3W&E7M
MKF,`//&5&9(S)8C,^!(9@[*_Z%S=Y,8.%.,I>49^2@F#$BR-?MP-;M7V[,IR
ME*BW"754>,D@((#VMW*)NP![0#6-\K["]N>;_P`R]VRG;[K.H=56W>A,RDQ>
M8BT3B[/!@?AED6R]T^:<6E$T-RF;",2-%=ZT0(NQB[XXX]2T>@"DQQGYJ\7J
M-DV&<<>7&ERC6-3>/[)2TF=OK"Q2&6!=R>*,_:V6)(IZ(BFD";PXA[P$-1<Y
M7[*>:V]4G@=_:WMJ9D1IW!-.N,O*9$>G,N6?5$#]F^N-^Y?CUQ0`Y#;583C'
M&K2#PJ%G)C3)$@V#@YDL,%)/B;F)QKS6K]-CW,=,E90J;<Z]=D)1&OV=L=T&
MZ"2M>G?MTJ90^PA_+2.7?W]0U''E/:?N/PN3\BV:\HVSD>M&,JE(D?\`B0$H
M??(+<G'^X7#>24HU]KW2VF994YD4ZG_#,B19^@3F>XH!N)B["&X#N&P@/L'?
MX#K7DB(@F18#-UFP(D`8X@JA54$RB8"F4Z=")]HG-[-NT#&*4?;\0T!!CJ&,
M?'HAE$%B0"JRF`P`/L_0?:'7;5-<6=PRJQ2[A\0_QTUQ\0BI,H!?AMMU'?8`
MUR5)$1&J6$4`HF/_`#)O\.X/_'7$3A)V(+9_#YJL2)_1C\L5CW)>6\88:K#Z
M[99R%3L;5&.355>6.[V.)K<0D"*0K*$*[EG35-98$RB()IB=0WN*.O?L.Q[U
MRN_.W\7MKJ^W!Q_+HTYU3]@A$L/$Y#JO#N&Z[7M%,5=UN:%M3D[&K4C!VS;4
M0Y'@,5KQ\D?R+L9O)IEAKQV8=O\`R_SS:I1S7JJ\+4K-#XU(_*H5!"1CF:;=
MO=+^CZ@BIZ;9"-9`@`JJ/2$#89L<)]C/,*&TCG/?7<K+BW;Z,8U)2,X5JQAF
M8/$F-.H1A'423/RB'5:FWGO#M4JDMMXA"6X[R08C2)-&63FF/,1]@`ZEE]7%
MSQ$YUY1W&K<IO-%D&4Y`7R&(YF\8<4I"725Q'AY[-O&4@Z5L</3G;"E3<@4C
M4K<\,W1<QWH`!7CA^(%*G;^XGN%X7P>VK\%]K5E+:=BG$4KK=B/\Y?QC&4/^
MUU2I1\Q(D&F"3I8G4>WC?#N0[U+\_P!Q*IJU2YIT!A",-6H:C$X$X`Q<'`:O
MI9;(["/8QK1JQ9-&S%HR:MF31JT2*V:MFC1,J+9LV03`B:#9ND0"D(4`*0H`
M`!L&H3U8BXB17E.H93UDRE(RE(G492D3J))Q+G'JMO4:=.A3A2HQC"G"(C&(
M#`1`8`#P`##P"[#7-=B-$1HB-$1HB-$1HB-$1HB-$2`.^_00V'W[=?VV$=$7
M%_R_^7^^B+E[0VVVZ:(J=B@8`VZ_^OZZ(J]$2``!OM[_`&Z(ET1)UW#KT]X:
M(@P;@(:(D``*4=_@._Z^W_;1$FW<4.WH&_O_`+_WT1+V[_Q=1_V_RT15:(C;
M?^X=]$1HBQGD+$6-\LQGVG(E,@;<R*FJD@:59E%\Q*J)#*#&RB!DI2-4,8A1
M$S=9(PB4.O35ZX_R?D/%+H7'';JXM)`N=%0L2,M4"\9?](%G5BW[C''N2T30
MWJSHUXF)CJD/,`?X9!I1QQP(Q#J)C-?B'BI$SZ0P7?7E?:.(]RU6H]W?R\FP
M4`X%$A8NTME5Y-ET2*4@.F[SM'J*@@)@U++@ON]WG;Z=.VYS8T[H1J1/KTM,
M:@`P>4"!&6&;&/R=BH^\F]NEI`3O>'W<J=<0PI5AZD3*.,0)2)SR.H.<S)LH
M9,Y<+N2.&8694MN'KRE#MX.77/88)4V0H!N=-J\'>1D:_)R"R+=0AC;HJ$1[
M$A'M3#WS9X#WV[6<SNK>AM.\6=*\-:`-&M_EZD291P'J0C'5D1($DX.3TC7N
MW:WN)M%77N=A7E+`RE2`G&..EQI)CJ$1JD02X`<F3`Q\V-"1&0G?3:V@[UNG
M%)?1-I`"H&<IJ20(`@(3Q%VO:J`J?3K'*5,R9!(4%`';?M"-O=6U*!%E<[;(
MS!)A&K`AH$ZAZ9<]!(1?,$LRUO4NH[?<0_.QC"H(2B'%2F2Q@<3&FP,2`!*+
MSEY@2Q\V1JGR\YFX9>2XT/-6>89@Q?,';6"D\BGGJ_Z!$(ILL8\=89J=BVZ2
MJZ0@!#(]G:!R]H"<1/@^[]E.S'+[>$MZV+:)79B8RJTJ1HS()E(,(THZB-32
MF"^6)TALPMNX7.^/PMX[7OU2W@!(RA+75A(XQ@2=,20(B,3$NTO-B73K*GYT
M.>]';E6L+6CY&8MWZ)U@N5)@8]R9%46YC1Y).E66#*9N<7`)IJBF8_J_*)Q#
MM$=.;U[&>R6ZF7Z?6O;"N01'T9SJ1@7+2$*L<1$8L2'CT=UF^V>Y?N+ME.-.
M]JV5_&)\T3"<3,1^II>F"`0"7.(&+`X)P$;^2;ER,[4;;P_JSM<5/3$(7)KN
M&$AU$FQD45$G4;9D2CWJF^<JYP.780`OM'7=[_MW;'5KFGMO*[B%(!Q.5H"^
M)Z:H8>.#_,N!F5+W<;@(Z:FT6LFQ>-:JQ#D.-5,'IX?UNW9R'Y.4@T%=`G"Q
M=5VFL9,A1S8@"*A"%]03CV8[,Y3,"9MA**8B!P$/@(^&/^W%*41(<O)!.0LL
M1_YO]2N-O[LS4I"=79Z0)Q;U3ABS%X9_(M_6F\W7\H'D:Y17+1>*.(ZX!E5"
MD>VVZW2U@W1]!91-1=M%-:B0#>H0-_G$!`HAV]=RY/M'^W/Q*E'7O/(MTNF_
M!;T8TI2Q&'J2-73@_P"%LEVGW/[C>:K?;MNH4[V4/(34,FDX?RR$01I=@3',
M%^ACMRGYPO+)R?G6=`QA=)RJR,X]<-(RD\8<<LVEMDE@,JU%JTD@-:<@*&1$
M!/NU=)]O8)A,(%`!VUMGM(]MW;:PCO\`RZPK581B3*INM]1]*F!B#Z=+RR,@
M`X,3\@7`LW^J_<7D]P+&C=>E7)&F%&$X'S`$!Z<2XQZR.8RS#F<`^"+R3\X[
M=$9%Y^93O^+*DX;#*K/\N9!>Y>S.\(]%-/[;"TM>S24;2'*R*(J+?<UVXMS&
M+_\`D5'O+K7?+/>CV&[/[9/:.SNTTKC?W].D;2,+6UB(@^;UA0]2H`2-1B^H
MN#-@"LWV_M3S7E5Q&YY+7E0H`.:E1IS/F)(%(M(8'`DC`.Y+-MI<+?&GQ(X'
M0B+?!&,&3.Z+0R$-8\L69VXLF3+:D02G=GD;$_.H$2TD7!"J*L(Q-E'B8A/Y
M/R%V^=7=/OIW.[P[A*YYGNE>K8^KKA;0(A:PS9J,0!(P<Z93U2BY8AV6^N*=
MON,<0A"IM](3W/T],J\@!.3XG"+1`)_A`^+I_!"B7NZ``=-MA$=^GZ^S;6H`
M2Y#`1&7Q\5FCR/U9=%6(`/MUR1*`;=`T1&B(T1&B(T1&B(T1&B(T1&B(T14C
MMN7<>N_3_+1$&VVZCL&^B)#=N_41`=O[>[1%7HB-$1HB-$1HB-$2==QZ=/<.
MB)=$2#[!W]FVB(#V!M[-M$2Z(C1%2;;8=Q$`VZ[?N'Z#KCAJ<Y-ET5<>F:X`
M!#8^P]-@[Q#?;;;IOL&VVVO-4_*>D/\`NWPT:G_Y/-]ZK(5-#5#Y6.;9=7=1
MT<K@\9>TB'*$V#0EA:C]>)N[^N02V6!(1_Z?@-S^K`_=Z';NMZFWI_-VZD1V
MN_\`T7ZD?]+_`->T=/2U^BV#OZW\K3D[X>/5:DYD.SI<<R.T";C_`!/3<%I:
M<L7;4S_V*$+,>-/`A:U["E!\B<RXNL1QB%'[VM57DM8F""*98\[5!-E9<4V!
MDJDX:E1(<45N\H&`1$#;"$U>)<C]^VU&V-WQ^QW2U$9Z!<U]JI5#C(2Q%[1+
M:M1Q#/EA@M#;EL?MVNJ<:FW;U6MJ;ST1A2G.B[U'SLY2PEK;SM]+8:4S.[\;
M_%VHH\/`>1R9;-SK)&:(63C#R'>^@W`O<DFY=5VN,@5W``(H95+;80,(;]@:
MW-LW<GW2B@([KVWMI5`/-*EO>U1U!QB(3K2TN?PB9;+40Y6J[_AW:N4#^C\O
MA&DTG]2PNB0'#O\`Y;$@LS`%LNJP:'&C@(9Y._2>2JF),QDV(K]_%OEB9(BI
M&+$JQ3D<58S$RBQP(("B;L+N&^YM@+?)=S._(C3_`/K2Y-3T@W_O6S-IU2;$
M77V'4-7V,L7NN%]NC2H"MS*UT"GY6V^_<QUS9]-L[NX\S%AX,5<U=XN^)8BA
MQR)Y/;`Z$)LBSE.H<5,Y1CLX`R,";-%W8J9-F2`6Y5!!0&QR[&`"^PNK;N/<
MWW33MVV'MI;4Y,P-QO>W3\WBU.YCAT;4/FKQM?#.SWJ`[KS$^D*+$4=OOP3'
M5F\K8@'H1\,4]G!^._QIJ3.-BV3/EBS'8!<JF,OF6NYXK]3!11!7L3<-8G%-
M$J1&S=L/3ZI90H@`=QC=-:5[B;[_`+B.[4":FRG:[8TPPVRK8U)B.&1I7EQ,
MEL"P!9\`MP<=VCVQV,J<JFZW%Z1TN*=S",L6Q:UI2'F8CS#$#IGL7<+0\>`U
M,X\%3<<2P/<X^XAA8*F,V)O7/Z_W_P"A`;5_]V^WUON]G3;7ST[HCN^=PF.Z
MAWP;AK#FZ]9A)NC@TW;-OM4F^(_Z>^C(\-_(>G^+T=.HX?B?SM^]^KI\I2I_
M\#FVVZ@`=!Z=!'Y=]]O9K5\XR.!DTNGTO\6P^]9O3$?)*F3Z3%ACI_I\ROIU
:S78C1$:(C1$:(C1$:(C1$:(C1$:(C1%__]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
